Results 201 to 210 of about 100,249 (267)

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow, Amanda Binkley, Jessica Meisner, Samantha Huo, Matthew Hinton   +4 more
wiley   +1 more source

Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024

Addiction, Volume 121, Issue 3, Page 680-685, March 2026.
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts, Rebecca McKetin, Caroline Copeland   +2 more
wiley   +1 more source

Sedative and Anxiolytic Activities of <i>Cassia spectabilis</i> Leaf Extract: An <i>In Vivo</i> and <i>In Silico</i> Evaluation in a Mouse Model of Stress. [PDF]

Vet Med Int
Ekasari W, Kurnia AI, Wirabuana RK, Angembani VMA, Prameswari ES, Suri WAA, Kristinawati S, Wahyuni TS, Ramadhan R, Putri NT, Suhartono E, Sahu RK.   +11 more
europepmc   +1 more source

Development of a High‐Risk Medication List for Australian Residential Aged Care: A Modified Delphi Study

Australasian Journal on Ageing, Volume 45, Issue 1, March 2026.
ABSTRACT Introduction High‐risk medications are medications associated with significant patient harm or death if misused or used in error. This study aimed to develop a national consensus high‐risk medication list for use in Australian residential aged care.
Amanda J. Cross, Madiha Chaudhry, Darshna Goordeen, Juanita L. Breen, Malcolm Clark, Stephanie Daly, Belinda Delardes, Bente Hart, Deborah Hawthorne, Peter J. Hayball, Sarah N. Hilmer, Lisa Kouladjian O’Donnell, MaryAnn Kulh, Kenneth Lee, David F. L. Liew, Stephen Macfarlane, Elizabeth Manias, Anthony Marinucci, Constance Dimity Pond, Helen Rawson, Susan Slatyer, Andrew Stafford, Amy B. Thomson, Kate Wang, Kirolos Wasef, Jonathan Zimmerman, Nadine E. Andrew, Gauri P. Godbole, Louise Lord, Atish Manek, Brigid McInerney, Michelle Steeper, Justin P. Turner, J. Simon Bell   +33 more
wiley   +1 more source

A dual-detection HPTLC platform: combining smartphone-based imaging and densitometry for the analysis of diazepam, its metabolite and degradation product. [PDF]

BMC Chem
Sherif M, Abdelkawy M, Boltia SA, ElDin NB.   +3 more
europepmc   +1 more source

Identifying Drugs Associated With Parkinson's Disease Risk Using Machine Learning

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 3, March 2026.
ABSTRACT Machine learning (ML)–based methods have been proposed as a potential approach for identifying candidate drugs to be repurposed as disease‐modifying treatments for Parkinson's disease (PD). We applied an ML‐based signal detection method to identify drugs associated with PD and evaluated the method's generalizability.
Eeva Pylkkö, Émeline Courtois, Anne Paakinaho, Sirpa Hartikainen, Valtteri Kaasinen, Alexis Elbaz, Anne C. M. Thiébaut, Ismaïl Ahmed, Anna‐Maija Tolppanen   +8 more
wiley   +1 more source

Fishery Anesthetics in Aquaculture Products: Safety Concerns and Analytical Methods. [PDF]

Foods
Jia BZ, Rui XY, Wang Y, Zeng X, Sheng SJ, Zeng BJ, Xu ZL, Luo L.   +7 more
europepmc   +1 more source

Managing High‐Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Nirmatrelvir boosted with ritonavir is a key antiviral against COVID‐19, yet ritonavir's potent CYP3A4 inhibition exposes patients to numerous drug–drug interactions. To make prescribing safer, a national proactive system providing expert pharmacology advice was implemented in France.
Youssef Libiad, Bénédicte Franck, Camille Tron, Sébastien Lalanne, Christelle Boglione‐Kerrien, Fabrice Taïeb, Marie‐Clémence Verdier, Florian Lemaitre   +7 more
wiley   +1 more source

Midazolam Oromucosal Solution for the Management of Prolonged Convulsive Seizures in Adult Outpatients: Addressing Unmet Needs in Europe. [PDF]

Clin Drug Investig
Carreño M, Kim-Wisskirchen IH, Forcadell Ferré M, Muñiz P, Valiante C.   +4 more
europepmc   +1 more source

Meta‐analysis of genetic mapping studies in mice reveals candidate epilepsy modifier genes that are outside the current drug development landscape

Epilepsia, Volume 67, Issue 3, Page 1421-1432, March 2026.
Abstract Objective Despite decades of development in anti‐seizure medications, ~30% of individuals remain refractory to all treatments, and none of the existing therapies are disease modifying. Identifying targets outside the current preclinical paradigm is critically important.
Giovanna L. Durante, Anna L. Tyler, Rod C. Scott, Amanda E. Hernan, J. Matthew Mahoney   +4 more
wiley   +1 more source